Showing results (371-380 of 400) with videos related to
Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2017
Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicityDianjun Cao, Qian M Cao, Sakthivel Subramaniam, et al.Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibitionA Thorarensen, M R Deibel, D C Rohrer, et al.Diabetes|September 28, 2022
Dynamic Ins2 Gene Activity Defines β-Cell Maturity StatesChieh Min Jamie Chu, Honey Modi, Cara Ellis, et al.Nature Communications|October 8, 2024
Transcriptional coactivator MED15 is required for beta cell maturationAlex Z Kadhim, Ben Vanderkruk, Samantha Mar, et al.Nature|December 6, 2019
c-Jun overexpression in CAR T cells induces exhaustion resistanceRachel C Lynn, Evan W Weber, Elena Sotillo, et al.Diabetologia|December 15, 2012
Identification and analysis of murine pancreatic islet enhancersB R Tennant, A G Robertson, M Kramer, et al.Nature Reviews. Immunology|October 2, 2019
Defining 'T cell exhaustion'Christian U Blank, W Nicholas Haining, Werner Held, et al.Molecular Neurodegeneration|March 18, 2020
Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiencyJonathan Frew, Alireza Baradaran-Heravi, Aruna D Balgi, et al.Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.Pageof 40